Atisa Life Sciences Private Limited
About Atisa Life Sciences Private Limited
Data last updated:
Atisa Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2010PTC071785. Its GSTIN is 36AAJCA2650E1ZY (Telangana).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹4.72 Cr. It is led by directors including Somasundaram Shanmugam and Udayalakshmi Suresh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No:42 – 315/1/2/C Maruthi Nagar A S Rao Nagar, Hyderabad, Telangana, India – 500062.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.5 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹54.11 Lakh (net margin -400.7%) and EBITDA of -₹41.21 Lakh (EBITDA margin -305.2%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 26% over five years.
The company is associated with 1 brand: Atisa Lifesciences.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Atisa Life Sciences has one previous CIN (Corporate Identification Number): U24233AP2010PTC071785. The current CIN is U24233TG2010PTC071785, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2010PTC071785 | Current |
| U24233AP2010PTC071785 | Previous |
Contact details
Atisa Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No:42 – 315/1/2/C Maruthi Nagar A S Rao Nagar, Hyderabad, Telangana, India – 500062
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Atisa Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Atisa Life Sciences operates one associated brand: Atisa Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies affordable medicines in oncology, nephrology, and hepatology sectors. | atisalifesciences.com |
Business activity
The main business activity of Atisa Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Atisa Life Sciences Private Limited, buy the company report.
Financials of Atisa Life Sciences Private Limited
FY 2025 filings availableAtisa Life Sciences Private Limited reported revenue of ₹13.5 Lakh (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 26% over five years, including a 20% fall in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹41.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹54.11 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -305.2% | ||||
| Net Profit Margin | -400.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Atisa Life Sciences Private Limited, buy the company report.
Board of directors of Atisa Life Sciences Private Limited
Atisa Life Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Somasundaram Shanmugam | Director | 21 Dec 2010 | 15 Years 10 Months | Current |
| Udayalakshmi Suresh Also directs: Serind Pharma Private Limited | Director | 31 Jul 2025 | 1 Years 2 Months | Current |
| Sandhya Nandiraju | Director | 31 Jul 2025 | 1 Years 2 Months | Current |
Peer comparison
Atisa Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Welfo Pharmaceutical Private Limited | ₹13.55 Lakh (FY 2022) | -58.0% | 24 Parganas, West Bengal, India | |||
| Eden Remedies Private Limited | ₹13.54 Lakh (FY 2024) | -89.0% | Delhi, India | |||
| Atisa Life Sciences Private Limitedthis company | ₹13.5 Lakh (FY 2025) | -₹54.11 Lakh | -400.7% | -20.0% | Hyderabad, Telangana, India | |
| Medic Lifesciences Private Limited | ₹13.48 Lakh (FY 2022) | 65.0% | Thane, Maharashtra, India | |||
| Arvind Laboratories Private Limited | ₹13.45 Lakh (FY 2025) | 31.0% | Ahmedabad, Gujarat, India | |||
| Guru SSR India Distributors Private Limited | ₹13.44 Lakh (FY 2022) | 36.0% | Pune, Maharashtra, India | |||
| Simca Medtech Private Limited | ₹13.43 Lakh (FY 2021) | -79.0% | Delhi, India |
To see the full peer comparison of Atisa Life Sciences Private Limited, buy the company report.
Auditor
Atisa Life Sciences Private Limited is audited by SRINIVASULU MANTHU & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SRINIVASULU MANTHU & ASSOCIATES | FY 2021 | 014080S |
Shareholding
The shareholding of Atisa Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Atisa Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Atisa Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atisa Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Atisa Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCA2650E1ZY | Telangana | Active | 23 Oct 2018 |
To see the full GST registrations and return filing status of Atisa Life Sciences Private Limited, buy the company report.
Recent activity
Atisa Life Sciences Private Limited has 5 board changes on record since 2010: 4 appointments and 1 cessation. The latest: Arcot Vijitha ceased to be Director on 01 Aug 2025.
Frequently asked questions
Atisa Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 December 2010 (16+ years old) and is registered under CIN U24233TG2010PTC071785.
Atisa Life Sciences has 3 current directors:
- Somasundaram Shanmugam - Director
- Udayalakshmi Suresh - Director
- Sandhya Nandiraju - Director
The latest financial statements of Atisa Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Atisa Life Sciences is 36AAJCA2650E1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Atisa Life Sciences is U24233TG2010PTC071785. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atisa Life Sciences was incorporated on 21 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Atisa Life Sciences by revenue are Welfo Pharmaceutical Private Limited, Eden Remedies Private Limited, Medic Lifesciences Private Limited, Arvind Laboratories Private Limited, Guru SSR India Distributors Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Arcot Vijitha ceased to be Director on 01 Aug 2025. Sandhya Nandiraju was appointed as Director on 31 Jul 2025. Udayalakshmi Suresh was appointed as Director on 31 Jul 2025. Atisa Life Sciences has 5 board changes on record in total.
The registered office of Atisa Life Sciences is at H.No:42 – 31512C Maruthi Nagar A S Rao Nagar, Hyderabad, Telangana, India – 500062.
Atisa Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Atisa Life Sciences is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.